Trytosaveabit commented on a stock · Jul 8 07:37

Update

$Outlook Therapeutics (OTLK.US)$ Reuters · 1 min ago Outlook Therapeutics® Announces UK Mhra Marketing Authorization of Lytenava™ (Bevacizumab Gamma) for the Treatment of Wet AMD

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3416 Views

Comment

Trytosaveabit

3590Followers

23Following

53KVisitors